GO:0046464 acylglycerol catabolic process: Lipid Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046464 acylglycerol catabolic process describes the biochemical breakdown of mono-, di-, and triesters of glycerol with fatty acids.
• The process is central to energy homeostasis, releasing free fatty acids and glycerol from stored triacylglycerols.
• Key enzymes include lipases such as ATGL, HSL, and MGL, which sequentially hydrolyze triacylglycerols to diacylglycerols, monoacylglycerols, and glycerol.
• Autophagy and lipid droplet dynamics are functionally linked to acylglycerol catabolism, influencing cellular lipid stores.
• Dysregulation of acylglycerol catabolic process is implicated in metabolic disorders, cancer, and neurodegeneration.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise interrogation of genes controlling acylglycerol catabolism.
Description
Acylglycerol catabolic process (GO:0046464) is a fundamental biological process that encompasses the chemical reactions and pathways resulting in the breakdown of acylglycerols, which are mono-, di-, or triesters of glycerol with one or more fatty acids. This process is essential for mobilizing stored lipids to meet cellular energy demands and for maintaining lipid homeostasis. Researchers study this term to understand how cells regulate fat storage and utilization, and how defects in these pathways contribute to metabolic diseases. The breakdown of acylglycerols occurs through sequential hydrolysis by lipases, releasing free fatty acids and glycerol, which can then enter energy-producing or signaling pathways. Given its central role in lipid metabolism, acylglycerol catabolic process is a key area of investigation in obesity, diabetes, cancer, and neurodegenerative disorders.
acylglycerol catabolic process At A Glance
| GO ID | GO:0046464 |
|---|---|
| GO term | acylglycerol catabolic process |
| Ontology | biological_process |
| Synonym | acylglycerol breakdown, acylglycerol catabolism, acylglycerol degradation |
| Major function | Breakdown of mono-, di-, and triacylglycerols into free fatty acids and glycerol |
| Related processes | Lipid catabolism, fatty acid oxidation, autophagy |
| Key enzymes | Lipases (e.g., ATGL, HSL, MGL) |
| Cellular location | Cytosol, lipid droplets, lysosomes |
What Is GO:0046464?
According to the Gene Ontology, acylglycerol catabolic process (GO:0046464) is defined as the chemical reactions and pathways resulting in the breakdown of acylglycerol, any mono-, di- or triester of glycerol with (one or more) fatty acids. This process includes the enzymatic hydrolysis of ester bonds linking fatty acids to the glycerol backbone, ultimately yielding free fatty acids and glycerol.
Why Is acylglycerol catabolic process Important in Cell Biology?
The acylglycerol catabolic process is vital for energy production and lipid homeostasis, as it mobilizes stored fats into free fatty acids and glycerol that can be oxidized for ATP or used in signaling. Its dysregulation is linked to obesity, insulin resistance, and cancer, making it a prime target for therapeutic intervention and metabolic research.
• Provides energy substrates through fatty acid oxidation.
• Maintains lipid homeostasis by preventing excessive lipid accumulation.
• Supports membrane remodeling and lipid signaling.
• Links to autophagy and lipid droplet turnover.
• Implicated in obesity and insulin resistance.
• Plays a role in cancer cell survival under metabolic stress.
• Contributes to neurodegeneration when impaired.
• Target for drugs modulating lipolysis.
• Essential for seed germination in plants.
• Key for understanding metabolic flexibility.
What Happens During acylglycerol catabolic process?
Initiation by Triacylglycerol Lipases
In simple terms: The first step is the removal of one fatty acid from a triacylglycerol molecule.
The catabolic process begins with the hydrolysis of triacylglycerols by lipases such as adipose triglyceride lipase (ATGL), which removes the first fatty acid to produce diacylglycerol and a free fatty acid. This step is rate-limiting and highly regulated by hormones and cellular energy status.
Diacylglycerol Hydrolysis
In simple terms: The second step removes another fatty acid from diacylglycerol.
Diacylglycerol is subsequently hydrolyzed by hormone-sensitive lipase (HSL) to yield monoacylglycerol and a second free fatty acid. HSL activity is controlled by phosphorylation in response to lipolytic stimuli.
Monoacylglycerol Cleavage
In simple terms: The final step releases the last fatty acid, leaving glycerol.
Monoacylglycerol lipase (MGL) catalyzes the hydrolysis of monoacylglycerol into glycerol and a third free fatty acid. This completes the breakdown of acylglycerols into glycerol and free fatty acids.
Fatty Acid and Glycerol Utilization
In simple terms: The products are used for energy or other cellular needs.
Free fatty acids are transported to mitochondria for beta-oxidation to generate ATP, while glycerol can be converted to glucose or used in glycolysis. These products also serve as signaling molecules and substrates for membrane lipid synthesis.
Integration with Autophagy
In simple terms: Autophagy helps deliver lipid droplets to lysosomes for breakdown.
Autophagy contributes to acylglycerol catabolism by targeting lipid droplets for lysosomal degradation, a process known as lipophagy. This pathway is particularly important under nutrient deprivation and in cells with high lipid stores.
Key Genes Involved in GO:0046464 acylglycerol catabolic process
The following genes encode key enzymes and regulators of the acylglycerol catabolic process, with their roles and research relevance summarized.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 | Adipose triglyceride lipase (ATGL); initiates triacylglycerol hydrolysis | Target for obesity and diabetes studies |
| LIPE | Hormone-sensitive lipase (HSL); hydrolyzes diacylglycerols | Regulated by phosphorylation; link to insulin resistance |
| MGLL | Monoacylglycerol lipase (MGL); cleaves monoacylglycerols | Involved in endocannabinoid signaling and cancer |
| ABHD5 | Co-activator of ATGL | Mutations cause Chanarin-Dorfman syndrome |
| PLIN1 | Lipid droplet coat protein; regulates lipolysis | Associated with familial partial lipodystrophy |
| PLIN2 | Lipid droplet protein; affects lipid storage | Marker of lipid accumulation in disease |
| PLIN5 | Lipid droplet protein; links to mitochondria | Regulates fatty acid oxidation |
| CIDEC | Lipid droplet protein; promotes lipid storage | Linked to lipodystrophy and insulin resistance |
| G0S2 | Inhibitor of ATGL | Modulates lipolysis in cancer and metabolism |
| CGI-58 | Co-activator of ATGL (same as ABHD5) | Regulates lipolysis and lipid signaling |
| ATGL | Alternative name for PNPLA2 | Key enzyme in lipolysis |
| HSL | Alternative name for LIPE | Rate-limiting enzyme in diacylglycerol hydrolysis |
| MGL | Alternative name for MGLL | Final step of acylglycerol catabolism |
| FABP4 | Fatty acid binding protein; transports fatty acids | Biomarker in metabolic disorders |
| LPL | Lipoprotein lipase; hydrolyzes plasma triacylglycerols | Target for hypertriglyceridemia |
| DGAT1 | Diacylglycerol acyltransferase; opposes catabolism | Balances lipid storage and breakdown |
| DGAT2 | Diacylglycerol acyltransferase; synthesizes triacylglycerols | Therapeutic target for fatty liver disease |
| CPT1A | Carnitine palmitoyltransferase 1A; fatty acid oxidation | Links catabolism to energy production |
How Is acylglycerol catabolic process Regulated?
The acylglycerol catabolic process is tightly regulated by hormonal signals (e.g., catecholamines, insulin), cellular energy status (AMPK, mTOR), and protein-protein interactions (e.g., ATGL and its co-activator ABHD5/CGI-58). Post-translational modifications such as phosphorylation of HSL and ATGL modulate their activity. Autophagy also contributes to regulation by delivering lipid droplets to lysosomes.
acylglycerol catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPLA2 | Neutral lipid storage disease with myopathy | Knockout mice, patient-derived iPSCs |
| LIPE | Familial partial lipodystrophy | Point mutation knock-in mice |
| MGLL | Cancer progression, neuroinflammation | Xenograft models, knockout cell lines |
| ABHD5 | Chanarin-Dorfman syndrome | Knock-in of patient mutations |
| PLIN1 | Lipodystrophy, insulin resistance | Overexpression and knockout models |
Metabolic Disorders
Dysregulation of acylglycerol catabolism contributes to obesity, insulin resistance, and type 2 diabetes, as impaired lipolysis leads to ectopic lipid accumulation and lipotoxicity. Genetic variants in PNPLA2, LIPE, and PLIN1 are associated with familial partial lipodystrophy and dyslipidemia.
Cancer
Cancer cells often rely on increased lipolysis to supply fatty acids for membrane synthesis and energy production, making enzymes like ATGL and MGL potential therapeutic targets. High expression of MGLL is linked to aggressive tumor phenotypes in some cancers.
Neurodegeneration
Impaired lipid catabolism is observed in neurodegenerative diseases such as Alzheimer's and Parkinson's, where lipid droplet accumulation and altered lipolysis contribute to neuronal dysfunction.
From acylglycerol catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PNPLA2 impair lipolysis? | PNPLA2 knockout cell line (e.g., HepG2, 3T3-L1) |
| How do point mutations in LIPE affect enzyme activity? | LIPE point-mutation knock-in via CRISPR |
| Can overexpression of MGLL enhance cancer cell proliferation? | MGLL overexpression in cancer cell lines |
| What is the role of PLIN1 in lipid droplet dynamics? | PLIN1 tagged knock-in for live imaging |
| Does ABHD5 deficiency alter autophagy? | ABHD5 knockout in primary fibroblasts |
| How does CPT1A modulation affect fatty acid oxidation? | CPT1A knockout and overexpression models |
How to Study the acylglycerol catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Relative abundance of acylglycerol species | Profiling lipid changes in knockout cells |
| Lipase activity assay | Enzymatic hydrolysis rate | Validating ATGL, HSL, MGL function |
| BODIPY staining | Lipid droplet number and size | Visualizing lipolysis in live cells |
| Western blot | Protein expression and phosphorylation | Assessing HSL activation |
| CRISPR knockout screen | Genes affecting lipid accumulation | Discovery of novel regulators |
| RNA-seq | Transcriptional changes in lipid metabolism | Pathway analysis after perturbations |
| Proteomics | Protein interactions and modifications | Identifying lipase complexes |
| Autophagy flux assay | Lipophagy activity | Linking autophagy to lipid breakdown |
Lipidomics and Mass Spectrometry
Lipidomics using mass spectrometry allows quantification of acylglycerol species and their catabolic products, providing a snapshot of pathway activity. This method is essential for profiling changes in lipid composition upon genetic or pharmacological perturbations.
Enzymatic Activity Assays
Lipase activity assays using fluorogenic or radiolabeled substrates measure the catalytic activity of enzymes like ATGL, HSL, and MGL in cell lysates or purified preparations. These assays are critical for validating gene function and screening inhibitors.
Imaging of Lipid Droplets
Fluorescence microscopy with lipid droplet dyes (e.g., BODIPY) or tagged proteins (e.g., PLIN1-GFP) enables visualization of lipid droplet dynamics and lipolysis in live cells. This approach reveals spatial and temporal aspects of acylglycerol catabolism.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of acylglycerol catabolism by selecting for cells with altered lipid content or survival under lipid stress. These screens provide unbiased discovery of pathway components.
How CRISPR Can Be Used to Study GO:0046464 acylglycerol catabolic process
Knockout
CRISPR knockout of genes such as PNPLA2, LIPE, or MGLL abolishes specific lipase activities, leading to lipid droplet accumulation and impaired fatty acid release. These models are used to study the contribution of individual enzymes to acylglycerol catabolism and to identify compensatory pathways.
Point Mutation
Introducing disease-associated point mutations (e.g., in PNPLA2 or LIPE) via CRISPR base editing or homology-directed repair allows researchers to dissect the functional impact of specific variants on enzyme activity and lipid metabolism. Such models mimic human genetic disorders.
Knock-in
Knock-in of tagged versions of lipases or lipid droplet proteins (e.g., PLIN1-GFP) enables live-cell imaging and proteomic analysis of acylglycerol catabolism components. This approach provides spatial and temporal resolution of the process.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of genes like MGLL or ATGL increases lipolytic capacity, useful for studying the effects of enhanced catabolism on cellular energetics and survival. Overexpression models help identify rate-limiting steps.
How EDITGENE Supports acylglycerol catabolic process Research
Researchers studying acylglycerol catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid breakdown, and to dissect its mechanism of action. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for acylglycerol catabolic process research.
Frequently Asked Questions About acylglycerol catabolic process
What is acylglycerol catabolic process?
Acylglycerol catabolic process (GO:0046464) is the breakdown of mono-, di-, and triesters of glycerol with fatty acids into free fatty acids and glycerol.
What genes are involved in acylglycerol catabolic process?
Key genes include PNPLA2 (ATGL), LIPE (HSL), MGLL (MGL), ABHD5, and PLIN1, among others.
What is the role of ATGL in acylglycerol catabolism?
ATGL (PNPLA2) initiates triacylglycerol hydrolysis by removing the first fatty acid, producing diacylglycerol and a free fatty acid.
How is acylglycerol catabolic process regulated?
It is regulated by hormones, energy status, and post-translational modifications of lipases, as well as by autophagy.
What diseases are linked to acylglycerol catabolic process?
Dysregulation is linked to obesity, insulin resistance, lipodystrophies, cancer, and neurodegeneration.
What methods are used to study acylglycerol catabolism?
Common methods include lipidomics, lipase activity assays, fluorescence imaging of lipid droplets, and CRISPR screens.
How can CRISPR be used to study acylglycerol catabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes to study their roles in lipid breakdown.
What is the difference between acylglycerol catabolic process and lipolysis?
Lipolysis is a key part of acylglycerol catabolism, specifically the hydrolysis of triacylglycerols into glycerol and free fatty acids.
Which organelles are involved in acylglycerol catabolic process?
Lipid droplets, cytosol, and lysosomes are major sites of acylglycerol catabolism.
Why is acylglycerol catabolic process important for energy metabolism?
It mobilizes stored fats to provide free fatty acids for beta-oxidation and ATP production, and glycerol for gluconeogenesis.
Conclusion
The acylglycerol catabolic process (GO:0046464) is a cornerstone of lipid metabolism, enabling cells to break down stored fats for energy and signaling. Its dysregulation underlies numerous metabolic and age-related diseases, making it a vibrant area of research. By leveraging CRISPR-based models and advanced analytical methods, scientists can uncover new therapeutic targets and deepen our understanding of this essential pathway.
References
- 1. HANAHAN DJ et al.. 1963. COMPLEX LIPIDS.. Annu Rev Biochem 32:215-40 PMID: 14144481
- 6. Xu C et al.. 2022. Links between autophagy and lipid droplet dynamics.. J Exp Bot 73(9):2848-2858 PMID: 35560198
